L1R, the recombinant vaccinia virus L1 protein, comes from the Vaccinia virus genome and is produced through recombinant genetic engineering. It plays a crucial role in the viral life cycle, serving as one of the primary proteins for viral entry into host cells and participating in the fusion of viral and cellular membranes. L1R's mechanism involves binding to host cell receptors, facilitating the entry of the viral particle core into the cytoplasm. This protein is vital for understanding the pathogenesis of poxviruses and for developing antiviral drugs and vaccines.
Validated Data
(Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
L1R Antibody (CSB-PA324949ZA01VAA)
Validated Data
Western Blot
Positive WB detected in Recombinant protein
All lanes: L1R antibody at 1:2000
Secondary
Goat polyclonal to rabbit IgG at 1/50000 dilution
Predicted band size: 26.8 kDa
Observed band size: 29 kDa
The following L1R reagents supplied by CUSABIO are manufactured under a strict quality control system. Multiple applications have been validated and solid technical support is offered.
L1R Antibodies for Vaccinia virus
| Code | Product Name | Species Reactivity | Application |
|---|---|---|---|
| CSB-PA324949ZA01VAA | L1R Antibody | Vaccinia virus | ELISA, WB |
L1R Proteins for Vaccinia virus (strain Copenhagen) (VACV)
| Code | Product Name | Source |
|---|---|---|
| CSB-CF324949VAA | Recombinant Vaccinia virus Protein L1 (L1R) | in vitro E.coli expression system |
| CSB-EP324949VAA1-B |
Recombinant Vaccinia virus Entry-fusion complex associated protein OPG095 (OPG099), partial | In Vivo Biotinylation in E.coli |
| CSB-EP324949VAA1 | Recombinant Vaccinia virus Entry-fusion complex associated protein OPG095 (OPG099), partial | E.coli |
| CSB-BP324949VAA1 | Recombinant Vaccinia virus Entry-fusion complex associated protein OPG095 (OPG099), partial | Baculovirus |
| CSB-YP324949VAA1 | Recombinant Vaccinia virus Entry-fusion complex associated protein OPG095 (OPG099), partial | Yeast |